UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $63
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $60 to $63.
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $60 to $63.